Blood eosinophil counts predict treatment response in patients with severe eosinophilic asthma
- 1 September 2015
- journal article
- Published by Elsevier in Journal of Allergy and Clinical Immunology
- Vol. 136 (3) , 825-826
Abstract
No abstract availableFunding Information
- GlaxoSmithKline
This publication has 5 references indexed in Scilit:
- High blood eosinophil counts predict sputum eosinophilia in patients with severe asthmaJournal of Allergy and Clinical Immunology, 2015
- Heterogeneity of phenotypes in severe asthmatics. The Belgian Severe Asthma Registry (BSAR)Respiratory Medicine, 2014
- Mepolizumab Treatment in Patients with Severe Eosinophilic AsthmaNew England Journal of Medicine, 2014
- Blood Eosinophil Count Is a Useful Biomarker to Identify Patients with Severe Eosinophilic AsthmaAnnals of the American Thoracic Society, 2014
- Mepolizumab for severe eosinophilic asthma (DREAM): a multicentre, double-blind, placebo-controlled trialThe Lancet, 2012